(Reuters) - Under the terms of the revised agreement, Beckman Coulter will acquire all of Biosite's outstanding common stock in a cash tender offer for $90 per share.
Beckman Coulter said the offer was valued at about $1.67 billion in total on a fully diluted share basis.
Read more at Reuters.com Mergers News
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment